Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes
about
The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host DiseaseBifidobacterium longum subspecies infantis: champion colonizer of the infant gutThe impact of the milk glycobiome on the neonate gut microbiotaMilk proteins, peptides, and oligosaccharides: effects against the 21st century disordersSialic acids as link to Japanese scientistsProlonged transition time between colostrum and mature milk in a bear, the giant panda, Ailuropoda melanoleucaMilk bioactives may manipulate microbes to mediate parent-offspring conflict.The sialate O-acetylesterase EstA from gut Bacteroidetes species enables sialidase-mediated cross-species foraging of 9-O-acetylated sialoglycans.Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine.Human milk and infant intestinal mucosal glycans guide succession of the neonatal intestinal microbiota.Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infantsDetection of sialic acid-utilising bacteria in a caecal community batch culture using RNA-based stable isotope probing.Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota.Gut biogeography of the bacterial microbiota.Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptationDietary Isomers of Sialyllactose Increase Ganglioside Sialic Acid Concentrations in the Corpus Callosum and Cerebellum and Modulate the Colonic Microbiota of Formula-Fed Piglets.Building a Beneficial Microbiome from Birth.Gut Microbiome Developmental Patterns in Early Life of Preterm Infants: Impacts of Feeding and Gender.Clinical applications of bioactive milk components.Characterization of porcine milk oligosaccharides during early lactation and their relation to the fecal microbiome.Neutral oligosaccharides in feces of breastfed and formula-fed infants at different ages.The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.The prebiotics 3'Sialyllactose and 6'Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut-brain axis.Human Milk Oligosaccharides and Synthetic Galactosyloligosaccharides Contain 3'-, 4-, and 6'-Galactosyllactose and Attenuate Inflammation in Human T84, NCM-460, and H4 Cells and Intestinal Tissue Ex VivoIs GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins.Growth and Morbidity of Gambian Infants are Influenced by Maternal Milk Oligosaccharides and Infant Gut Microbiota.Preferential packing of acidic glycosidases and proteases into Bacteroides outer membrane vesicles.The Role of Mucosal Immunity in the Pathogenesis of Necrotizing Enterocolitis.Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial.Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides.The microbiome in early life: self-completion and microbiota protection as health priorities.Solubilization and Iterative Saturation Mutagenesis of α1,3-fucosyltransferase from Helicobacter pylori to enhance its catalytic efficiency.The intestinal glycome and its modulation by diet and nutrition.Patterns of Early-Life Gut Microbial Colonization during Human Immune Development: An Ecological PerspectiveComposition and Variation of Macronutrients, Immune Proteins, and Human Milk Oligosaccharides in Human Milk From Nonprofit and Commercial Milk Banks.Impact of probiotics on necrotizing enterocolitis.Preparative scale purification of fucosyl-N-acetylglucosamine disaccharides and their evaluation as potential prebiotics and antiadhesins.Comparative composition, diversity, and abundance of oligosaccharides in early lactation milk from commercial dairy and beef cows.FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk.
P2860
Q26751265-345FC1BC-5246-420F-A60E-3EA59C1B4FD5Q26823017-CA1CACFD-0EB9-4C55-AB33-BA82665A8548Q26860976-238900B0-BA46-4CF9-86CA-1CFF622B7046Q27023113-5EFFA10D-2D24-4EA8-8381-37172279FE1FQ28077544-58671D09-5A72-4D6E-8344-3D6CC2B97448Q28608080-DEDFF848-E001-4D44-8356-9524D93A58F0Q30406244-EFCFFFD0-C373-4609-B83A-D79566BADFACQ33907419-8BC03A0E-65AF-4B53-9B3D-9C7DC3CA5F3FQ34283105-3780D6E6-B926-4256-AC7A-ADE8A7D52A72Q35377436-80462878-020C-45E0-ADC0-DE0C8BE3BE0BQ35545529-C26B9350-984A-4864-AA1E-4353F062F759Q35585821-322B2E6C-BCB3-4932-8F19-3BA0FB6ACAEEQ35760148-3F628679-B778-42FE-9E2E-896E0F2D9E07Q35820919-2FDC8E8E-D0FB-4F91-ABDC-8C9C7256D485Q35877592-FF1D97BD-CAF2-492C-9669-1167CAAD5DCEQ35877966-CF246528-488C-4D4C-B15B-68CAFFA71726Q35958916-1955E0F7-BBB7-45B7-99E1-A7F77B7CA171Q35998394-9AB155B4-115E-49B5-AC69-6D57E7442C5BQ36027779-890B66D1-8CAE-4E7C-815D-FA9B3AD9E8D3Q36103696-901F1FAF-A004-4B7D-A977-2E9B480A1579Q36129225-C79C1041-9A40-48CD-8934-71CE60F04E60Q36133332-E7C72C5D-0E89-4178-BF85-AE16F4B8C69DQ36158407-90F54582-5905-435B-84D4-32643C79B61CQ36244829-4F5EBB25-7D3C-4F26-B4A1-B2E42A2B704BQ36498047-DD17D4EF-313F-4AD9-928E-B483A388E0D4Q37330296-8F45091C-8AE9-45BB-A4C3-4DDB03D1036CQ37581514-653D55AE-911C-4751-88B0-AED3593EDBA1Q37634455-3C1C52A9-351C-43A1-805A-9FE96C1AC593Q37677906-B1A207E9-A09E-456C-8D0E-2006F4DF404EQ37735335-4F0B75E3-3CD7-42C4-BFF3-8C62445BD48FQ38211778-83432BB9-E348-4D3F-9BA1-80B96113304AQ38231994-6C53FCBC-3C81-4652-ADB3-7C9920552037Q38294196-2F51F0D9-EAC7-4B21-BA93-328A316508A7Q38503059-F7EE0835-4919-496C-A2A4-2782970C76AEQ38663368-9F1A4D48-DB30-4841-870A-8DF5A4AB8A7AQ38725675-E596FBD8-255C-49D6-848B-1EED13BD9B29Q38796288-C9F7B5DB-EFAD-4AA2-A348-892EEC5E2C29Q38874566-46FB146F-92C3-47A5-8866-39A43E079622Q38894268-524BB6BB-F530-4F9B-99E2-830FD6854BD8Q39975367-65F7D4BB-BF73-4C98-A3ED-00310C8F556D
P2860
Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Utilization of major fucosylat ...... by isolated human gut microbes
@ast
Utilization of major fucosylat ...... by isolated human gut microbes
@en
Utilization of major fucosylat ...... by isolated human gut microbes
@nl
type
label
Utilization of major fucosylat ...... by isolated human gut microbes
@ast
Utilization of major fucosylat ...... by isolated human gut microbes
@en
Utilization of major fucosylat ...... by isolated human gut microbes
@nl
prefLabel
Utilization of major fucosylat ...... by isolated human gut microbes
@ast
Utilization of major fucosylat ...... by isolated human gut microbes
@en
Utilization of major fucosylat ...... by isolated human gut microbes
@nl
P2093
P2860
P356
P1433
P1476
Utilization of major fucosylat ...... by isolated human gut microbes
@en
P2093
David S Newburg
Zhuo-Teng Yu
P2860
P304
P356
10.1093/GLYCOB/CWT065
P577
2013-09-07T00:00:00Z